Strain Information | |
---|---|
Image | |
BRC No. | RBRC05638 |
Type | Targeted Mutation![]() |
Species | Mus musculus |
Strain name | B6;129-Nov<tm1Hko> |
Former Common name | CCN3 KO, B6-Nov KO, B6;129-Nov<tm1Hko>, B6;129-Nov<tm1Hko>/HkoRbrc |
H-2 Haplotype | |
ES Cell line | R1 [(129X1/SvJ x 129S1/Sv)F1-Kitl<+>] |
Background strain | |
Appearance | |
Strain development | Developed by Haruhiko Koseki, RIKEN Center for Allergy and Immunology. R1 ES cells derived from (129X1/SvJ x 129S1/Sv)F1-Kitl<+> were used for the generation of knockout mice. The mutant mice were crossed to C57BL/6J. |
Strain description | Nov (CCN3) gene knockout mice. Exons 1, 2 and 3 of Nov gene were replaced with a neomycin selection cassette. Homozygous mutant mice show no obvious abnormality. Homozygous mutant mice exhibit enhanced neointimal hyperplasia in vascular smooth muscles induced by endothelial injury. |
Colony maintenance | Homozygote x Homozygote [or Crossing to C57BL/6JJcl] |
References | CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migration. Shimoyama T, Hiraoka S, Takemoto M, Koshizaka M, Tokuyama H, Tokuyama T, Watanabe A, Fujimoto M, Kawamura H, Sato S, Tsurutani Y, Saito Y, Perbal B, Koseki H, Yokote K Arterioscler. Thromb. Vasc. Biol., 30, 675-682 (2010). 20139355 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Ccn3 MGI:109185 | cellular communication network factor 3 | 15 | Ccn3<tm1Hko> MGI:5004902 | targeted mutation 1, Haruhiko Koseki | |||
neo | neomycin resistance gene (E. coli) | 15 | mouse phosphoglycerate kinase promoter (PGK promoter) |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | mouse phosphoglycerate kinase promoter (PGK promoter), E.coli Neomycin resistance gene, mouse Nov genomic DNA |
Research application | |
Specific Term and Conditions | The RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. |
Depositor | Haruhiko Koseki (RIKEN) |
Strain Status | ![]() ![]() |
Strain Availability | Recovered litters from cryopreserved sperm (2 to 4 months) Cryopreserved sperm (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |